• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

alexion-logo

Rare Disease

Alexion, AstraZeneca Rare Disease Unit, is pleased to present healthcare professionals with a variety of Rare Disease resources for your informational purposes. The educational materials are intended to provide information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

November 12-15, 2023

International Society for Pharmacoeconomics and Outcomes Research - 26th Annual European Congress

Explore AstraZeneca Scientific Materials Visit website

October 11-15, 2023

IDWeek 2023

Explore AstraZeneca Scientific Materials Visit website

This page provides access to AstraZeneca presentations and posters shared during the congresses listed below. Content availability is subject to the timeliness and permissions outlined by respective congresses.

EAN 2025

European Academy of Neurology 11th Congress, Helsinki 2025

 

June 21 - 24, 2025

Visit website

 

 

EHA 2025

European Hematology Association

 

June 12 - 17, 2025

Visit website

 

 

ERA 2025

European Renal Association (ERA) 62nd Congress, Vienna & Virtual

 

June 04 - 07, 2025

Visit website

 

 

ESPE-ESE 2025

European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE)

 

May 10 - 13, 2025

Visit website

 

 

AAN 2025

American Academy of Neurology: (AAN 2025)
77th Annual Meeting

 

April 5 - April 9, 2025

Visit website

 

 

EBMT 2025

European Society for Blood and Marrow Transplantation

 

March 30 - April 2, 2025

Visit website

 

 

ASH 2024

American Society of Hematology Annual Meeting and Exposition

 

December 07 - 10, 2024

Visit website

 

 

ASN 2024

American Society of Nephrology Kidney Week

 

October 24 - 27, 2024

Visit website

 

 

AANEM 2024

American Association of Neuromuscular & Electrodiagnostic Medicine

 

October 15 - 18, 2024

Visit website

 

 

ASBMR 2024

American Society for Bone and Mineral Research 

 

September 27 - 30, 2024

Visit website

 

 

ECTRIMS 2024

European Committee for Treatment and Research in Multiple Sclerosis

 

September 18 - 20, 2024

Visit website

 

 

ESC 2024

European Society of Cardiology

 

August 30 - September 02, 2024

Visit website

 

 

CTF 2024

Children's Tumor Foundation

 

June 20 - 25, 2024

Visit website

 

 

EHA 2024

European Hematology Association

 

June 13 - 16, 2024

Visit website

 

 

pipeline

  • KANUMA<sup>®</sup> (sebelipase alfa) injection, for intravenous use
  • KOSELUGO<sup>®</sup> (selumetinib) capsules, for oral use
  • SOLIRIS<sup>®</sup> (eculizumab) injection, for intravenous use
  • STRENSIQ<sup>®</sup> (asfotase alfa) injection, for subcutaneous use
  • ULTOMIRIS<sup>®</sup> (ravulizumab-cwvz) injection, for intravenous use
  • VOYDEYA<sup>™</sup> (danicopan) tablets, for oral use

Email Recipient

  1. Colleague
  2. Myself

VIDEO

WEBSITE

Request a field medical follow-up

AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

M/US/ALL/0006 Last Updated 09/23

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice